Antithrombotic Effects of Ionic and Non-ionic Contrast Media in Nonhuman Primates

 

 Buy Article Permissions and Reprints

Summary

Thromboembolic complications have been attributed to the use of radiographic contrast media (CM) during interventional procedures for arterial revascularization. However, due to the low frequency of adverse events, comparisons between different CM have been difficult to perform, although it has been suggested that ionic (vs. non-ionic) CM may be associated with fewer thrombotic events. The present study was undertaken using well-characterized baboon thrombosis models in order to compare different CM under physiologically relevant and controlled conditions of blood flow, exposure time, and CM concentration. Three CM were studied: ioxaglate, iohexol, and iodixanol. CM were locally infused into the proximal segment of femoral arteriovenous shunts. Palmaz-Schatz stents (4 mm i.d.) and expanded tubular segments (9 mm i.d.), which exhibited venous-type flow recirculation and stasis, were deployed into the shunts distally. Saline was infused in identical control studies. Blood flow was maintained at 100 ml/min. Thrombosis was measured over a blood exposure period of 2 hours by gamma camera imaging of 111In-platelets and by gamma counting of deposited 125I-fibrin. CM concentrations within the flowfield were predicted using computational fluid dynamics. At infusion rates of 0.1 and 0.3 ml/min, the low-osmolar ionic CM ioxaglate reduced both platelet and fibrin deposition on the stents by 75-80% (p <0.005), while both iohexol and iodixanol reduced platelet deposition by 30-50% (p <0.05). In the regions of low shear flow, ioxaglate (0.3 ml/min) also reduced platelet deposition significantly (by 52% vs. control results; p <0.05). Thus the three agents evaluated – ioxaglate, iohexol, and iodixanol – all produced anticoagulant and antiplatelet effects and were inherently antithrombotic in vivo. The most striking effects were seen with the low osmolarity, ionic contrast agent ioxaglate.

• References

• 1 Chronos N. Implications of Contrast Media Selection in Interventional Cardiology. In: Interventional Cardiology. Topol EJ, and Serruys PW. eds. Philadelphia: Current Science/Medicine; 1995: 280-93.
  Google Scholar
• 2 Fareed J, Walenga JM, Saravia GE, Moncada RM. Thrombogenic potential of nonionic contrast media?. Radiology 1990; 174: 321-5.
  CrossrefPubMedGoogle Scholar
• 3 Chronos NA, Goodall AH, Wilson DJ, Sigwart U, Buller NP. Profound platelet degranulation is an important side effect of some types of contrast media used in interventional cardiology. Circulation 1993; 88: 2035-44.
  CrossrefPubMedGoogle Scholar
• 4 Hardeman MR, Konijnenberg A, Sturk A, Reekers JA. Activation of platelets by low-osmolar contrast media: differential effects of ionic and nonionic agents. Radiology 1994; 192: 563-6.
  CrossrefPubMedGoogle Scholar
• 5 Hay KL, Bull BS. An analysis of platelet activation and aggregation produced by three classes of contrast media. J Vasc Int Radiol 1995; 6: 211-7.
  CrossrefPubMedGoogle Scholar
• 6 Grabowski EF, Rodriguez M, McDonnell SL. Platelet adhesion/aggregation in an in vitro model of coronary artery stenosis. Cathet Cardiovasc Diagn 1993; 28: 65-71.
  CrossrefPubMedGoogle Scholar
• 7 Heptinstall S, White A, Edwards N, Pascoe J, Sanderson HM, Fox SC, Henderson RA. Differential effects of three radiographic contrast media on platelet aggregation and degranulation: implications for clinical practice?. Br J Haematol 1998; 103: 1023-30.
  CrossrefPubMedGoogle Scholar
• 8 Melton LG, Muga KM, Gabriel DA. Effect of contrast media on in vitro bleeding time: assessment by a hollow fiber instrument. Acad Radiol 1995; 2: 239-43.
  CrossrefPubMedGoogle Scholar
• 9 Li X, Gabriel DA. Differences between contrast media in the inhibition of platelet activation by specific platelet agonists. Acad Radiol 1997; 4: 108-14.
  CrossrefPubMedGoogle Scholar
• 10 Sakariassen KS, Barstad RM, Hamers MJ, Stormorken H. Iohexol, platelet activation and thrombosis. I. Iohexol-induced platelet secretion does not affect thrombus formation in native blood. Acta Radiol 1998; 39: 349-54.
  PubMedGoogle Scholar
• 11 Levi M, Biemond BJ, Stuck A, Wouter ten Cate J. The effect of radiological contrast media in animal models of experimental thrombosis. Semin Hematol 1991; 28: 27-30.
  PubMedGoogle Scholar
• 12 Aguejouf O, Doutremepuich F, Azougagh OF, Doutremepuich C. Thrombogenicity of ionic and nonionic contrast media tested in a laser induced rat thrombosis model. Thromb Res 1995; 77: 259-69.
  CrossrefPubMedGoogle Scholar
• 13 Corot C, Stucker O, Duverger JP, Pons C, Vicaut E. Effects of iodinated contrast agents on the formation of platelet thrombi in rat arterioles. Invest Radiol 1994; 29 (Suppl. 02) S203-S205.
  CrossrefPubMedGoogle Scholar
• 14 Esplugas E, Cequier A, Jara F, Mauri J, Soler T, Sala J, Sabate X. Risk of thrombosis during coronary angioplasty with low osmolality contrast media. Am J Cardiol 1991; 68: 1020-4.
  CrossrefPubMedGoogle Scholar
• 15 Lefevre T, Bernard A, Bertrand M, Lablanche JM, Cequier A, Espuglas E, Gayet JL, Gosselin G, Bonan R. Electron microscopic comparison of the antithrombotic potential of 2 low osmolality iodine contrast media in percutaneous transluminal coronary angioplasty. Archives des Maladies du Coeur et des Vaisseaux 1994; 87: 225-33.
  PubMedGoogle Scholar
• 16 Grines CL, Schreiber TL, Savas V, Jones DE, Zidar FJ, Gangadharan V, Brodsky M, Levin R, Safian R, Puchrowicz-Ochocki S, Castellani MD, O’Neill WW. A randomized trial of low osmolar ionic versus nonionic contrast media in patients with myocardial infarction or unstable angina undergoing percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1996; 27: 1381-6.
  CrossrefPubMedGoogle Scholar
• 17 Qureshi NR, den Heijer P, Crijns HJ. Percutaneous coronary angioscopic comparison of thrombus formation during percutaneous coronary angioplasty with ionic and nonionic low osmolality contrast media in unstable angina. Am J Cardiol 1997; 80: 700-4.
  CrossrefPubMedGoogle Scholar
• 18 Malekianpour M, Bonan R, Lesperance J, Gosselin G, Hudon G, Doucet S, Laurier J, Duval D. Comparison of ionic and nonionic low osmolar contrast media in relation to thrombotic complications of angioplasty in patients with unstable angina. Am Heart J 1998; 135: 1067-75.
  CrossrefPubMedGoogle Scholar
• 19 Schrader R, Esch I, Ensslen R, Fach WA, Merle H, Scherer D, Sievert H, Spies HF, Zeplin HE. A randomized trial comparing the impact of a nonionic (Iomeprol) versus an ionic (Ioxaglate) low osmolar contrast medium on abrupt vessel closure and ischemic complications after coronary angioplasty. J Am Coll Cardiol 1999; 33: 395-402.
  CrossrefPubMedGoogle Scholar
• 20 Corot C, Cornillac A, Belleville J, Eloy R. Scanning electron microscopic analysis of catheters during routine angiographic procedures. Role of the contrast agent. Invest Radiol 1991; 26 (Suppl. 01) S96-S100.
  CrossrefPubMedGoogle Scholar
• 21 Krupski WC, Bass A, Kelly AB, Marzec UM, Hanson SR, Harker LA. Heparin-resistant thrombus formation by endovascular stents in baboons. Interruption by a synthetic antithrombin. Circulation 1990; 82: 570-7.
  CrossrefPubMedGoogle Scholar
• 22 Gruber A, Hanson SR, Kelly AB, Yan BS, Bang N, Griffin JH, Harker LA. Inhibition of thrombus formation by activated recombinant protein C in a primate model of arterial thrombosis. Circulation. 1990; 82: 578-85.
  CrossrefPubMedGoogle Scholar
• 23 Vyavahare N, Scott N, Hanson SR, Kohn J. In vitro and in vivo evaluation of the site-specific administration of the thrombin inhibitor D-Phe-Pro-Arg chloromethyl ketone. J Controlled Release 1993; 27: 165-73.
  CrossrefPubMedGoogle Scholar
• 24 Hanson SR, Griffin JH, Harker LA, Kelly AB, Esmon CT, Gruber A. Antithrombotic effects of thrombin-induced activation of endogenous protein C in primates. J Clin Invest 1993; 92: 2003-12.
  CrossrefPubMedGoogle Scholar
• 25 Hanson SR, Kotze HF, Savage B, Harker LA. Platelet interactions with Dacron vascular grafts. A model of acute thrombosis in baboons. Arteriosclerosis 1985; 5: 595-603.
  CrossrefPubMedGoogle Scholar
• 26 Markou CP, Lutostansky EM, Ku DN, Hanson SR. A novel method for efficient drug delivery. Ann Biomed Eng 1998; 26: 502-11.
  CrossrefPubMedGoogle Scholar
• 27 Chen C, Hanson SR, Lumsden AB. Boundary layer infusion of heparin prevents thrombosis and reduces neointimal hyperplasia in venous polytetrafluoroethylene grafts without systemic anticoagulation. J Vasc Surg 1995; 22: 237-45.
  CrossrefPubMedGoogle Scholar
• 28 Mattar SG, Hanson SR, Pierce GF, Chen C, Hughes JD, Cook JE, Shen C, Noe BA, Suwyn CR, Scott JR, Lumsden AB. Local infusion of FGFsaporin reduces intimal hyperplasia. J Surg Res 1996; 60: 339-44.
  CrossrefPubMedGoogle Scholar
• 29 Saavedra JE, Southan GJ, Davies KM, Lundell A, Markou C, Hanson SR, Adrie C, Hurford WE, Zapol WM, Keefer LK. Localizing antithrombotic and vasodilatory activity with a novel, ultrafast nitric oxide donor. J Med Chem 1996; 39: 4361-5.
  CrossrefPubMedGoogle Scholar
• 30 Chen C, Mattar SG, Hughes JD, Pierce GF, Cook JE, Ku DN, Hanson SR, Lumsden AB. Recombinant mitotoxin basic fibroblast growth factor-saporin reduces venous anastomotic intimal hyperplasia in the arteriovenous graft. Circulation 1996; 94: 1989-95.
  CrossrefPubMedGoogle Scholar
• 31 Corot C, Chronos N, Sabattier V. In vitro comparison of the effects of contrast media on coagulation and platelet activation. Blood Coag Fibrinol 1996; 7: 602-8.
  CrossrefPubMedGoogle Scholar
• 32 Sakariassen KS, Muggli R, Baumgartner HR. Measurements of platelet interaction with components of the vessel wall in flowing blood. Methods Enzymol 1989; 169: 37-70.
  PubMedGoogle Scholar
• 33 Sakariassen KS, Joss R, Muggli R, Kuhn H, Tschopp TB, Sage H, Baumgartner HR. Collagen type III induced ex vivo thrombogenesis in humans. Role of platelets and leukocytes in deposition of fibrin. Arteriosclerosis 1990; 10: 276-84.
  CrossrefPubMedGoogle Scholar
• 34 Sakariassen KS, Buchmann M, Hamers MJ, Stormorken H. Iohexol, platelet activation and thrombosis. II. Iohexol-induced platelet secretion does not affect collagen-induced or tissue-factor-induced thrombus formation in blood that is anticoagulated with heparin and aspirin. Acta Radiol 1998; 39: 355-61.
  PubMedGoogle Scholar
• 35 Aguirre FV, Simoons ML, Ferguson JJ, FitzPatrick SE, Anderson KM, Kern MJ, Tcheng JE. Impact of contrast media on clinical outcomes following percutaneous coronary interventions with platelet glycoprotein IIb/IIIa inhibition: meta-analysis of clinical trials with Abciximab. Circulation 1997; 96 (Suppl. 01) 161 (Abstract).
  PubMedGoogle Scholar